HONG KONG (Reuters) – Hong Kong said on Wednesday it had approved the baby version of the BioNTech COVID-19 vaccine for babies and children under five years old, part of broader measures to boost vaccination uptake in the financial hub.
(Reporting by Twinnie Siu, Farah Master and Marius Zaharia; editing by Andrew Heavens)
